Habitat-specific differences alter traditional biogeographic patterns of life history in a climate-change induced range expansion

por Riley, Megan E., Griffen, Blaine D.
Publicado 2017

18. An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Clinical Trials

por Andrew, Melissa K, Matthews, Sean, Kim, Joon Hyung, Riley, Megan, Curran, Desmond
Publicado 2021

An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Vaccine Clinical Trials

por Andrew, Melissa K, Matthews, Sean, Kim, Joon Hyung, Riley, Megan E, Curran, Desmond
Publicado 2022

08. Concomitant Administration of the Adjuvanted Recombinant Zoster Vaccine (RZV) with 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Is Safe and Does Not Interfere with Immunoge...

por Min, Ji-Young, Mwakingwe-Omar, Agnes, Riley, Megan, Molo, Lifeter Yenwo, Soni, Jyoti, Girard, Ginette, Danier, Jasur
Publicado 2021

Laboratory Animal Welfare Meets Human Welfare: A Cross-Sectional Study of Professional Quality of Life, Including Compassion Fatigue in Laboratory Animal Personnel

por LaFollette, Megan R., Riley, Megan C., Cloutier, Sylvie, Brady, Colleen M., O'Haire, Marguerite E., Gaskill, Brianna N.
Publicado 2020

Adverse infant outcomes following low-risk pregnancies in England: a retrospective cohort study

por Riley, Megan, Lambrelli, Dimitra, Graham, Sophie, Henry, Ouzama, Sutherland, Andrea, Schmidt, Alexander, Sawalhi-Leckenby, Nicola, Donaldson, Robert, Stoszek, Sonia K.
Publicado 2023

Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England

por Riley, Megan, Lambrelli, Dimitra, Graham, Sophie, Henry, Ouzama, Sutherland, Andrea, Schmidt, Alexander, Sawalhi-Leckenby, Nicola, Donaldson, Robert, Stoszek, Sonia K.
Publicado 2022

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

por Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne, Oostvogels, Lidia, Curran, Desmond
Publicado 2019

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

por Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan E, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne E, Oostvogels, Lidia, Curran, Desmond
Publicado 2020

5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studi...

por Andrew, Melissa K, Kim, Joon Hyung, Matthews, Sean, Dessart, Christophe, levin, myron J, Oostvogels, Lidia, Riley, Megan, Schmader, Kenneth E, McNeil, Shelly, Schuind, Anne, Curran, Desmond
Publicado 2020

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

por Curran, Desmond, Kim, Joon H., Matthews, Sean, Dessart, Christophe, Levin, Myron J., Oostvogels, Lidia, Riley, Megan E., Schmader, Kenneth E., Cunningham, Anthony L., McNeil, Shelly A., Schuind, Anne E., Andrew, Melissa K.
Publicado 2020